AC Immune (ACIU) Total Liabilities (2015 - 2026)

AC Immune (ACIU) has 12 years of Total Liabilities data on file, last reported at $135.2 billion in Q1 2026.

• On a quarterly basis, Total Liabilities rose 104447.23% year-over-year to $135.2 billion in Q1 2026; TTM through Mar 2026 was $135.2 billion, a 104447.23% increase from a year earlier, with the FY2025 full-year figure at $131.9 million, down 2.6% from the prior year.
• Total Liabilities for Q1 2026 stood at $135.2 billion, up from $136.8 million in the prior quarter.
• Over the last five years, Total Liabilities for ACIU reached as high as $135.2 billion in Q1 2026 and fell as low as $14509.1 in Q2 2022.
• Historically, Total Liabilities has averaged $8.0 billion across 5 years, with a median of $25.9 million in 2024.
• Across the five-year window, Total Liabilities slumped 44.95% in 2022 and soared 129444.62% in 2023, its largest moves.
• Year by year, Total Liabilities stood at $17.6 million in 2022, then jumped by 42.08% to $25.0 million in 2023, then surged by 441.85% to $135.4 million in 2024, then rose by 1.04% to $136.8 million in 2025, then soared by 98717.21% to $135.2 billion in 2026.
• Per Business Quant data, the three most recent Total Liabilities figures were $135.2 billion in Q1 2026, $136.8 million in Q4 2025, and $136.5 million in Q3 2025.